Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.570
+0.110 (7.53%)
Nov 12, 2025, 1:42 PM EST - Market open
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $48.65 million as of November 12, 2025. Its market cap has decreased by -67.15% in one year.
Market Cap
48.65M
Enterprise Value
10.25M
1-Year Change
-67.15%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $48.65M, a decrease of -86.34%. That is a compound annual growth rate of -71.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 44.00M | -48.78% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 865.51B |
| Johnson & Johnson | 453.94B |
| AbbVie | 386.54B |
| UnitedHealth Group | 291.30B |
| AstraZeneca | 267.87B |
| Novartis AG | 243.29B |
| Abbott Laboratories | 218.91B |
| Thermo Fisher Scientific | 216.54B |